Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001851416-26-000006·20/20 Biolabs, Inc.
Schedule 13G ownership disclosure
20/20 BIOLABS INC
Common Stock · CUSIP: 90138K101
Event date: 2026-02-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Streeterville Capital LLC
Shares: 543,680.00 · Class: 9.9%
- Streeterville Management, LLC
Shares: 543,680.00 · Class: 9.9%
- John M Fife
Shares: 543,680.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001851416-26-000006
- Form type
- SCHEDULE 13G
- Filer
- 20/20 Biolabs, Inc.
- CIK
- CIK 1139685
- Filed
- Feb 25, 2026
- Reporting period
- Feb 25, 2026
- Description
- Schedule 13G beneficial ownership